Pathological mitochondrial retrograde signaling as a disease modifier in patients

In the first part of my talk I will briefly present and discuss the key findings of a study we recently completed that identified pathological mitochondrial retrograde signaling as a disease modifier in patients with primary antibody deficiency. I will then change gear and present unpublished work-in-progress on iron homeostasis in NK cells.

If you would like to attend this seminar, please contact us to arrange site access.